News from NIAID-Supported Institutions

News from NIAID-Supported Institutions

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases

News from NIAID-Supported Institutions

National Institute of Allergy and Infectious Diseases sent this bulletin at 01/10/2014 03:06 PM EST

Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Genetically Identical Bacteria Can Behave in Radically Different Ways
December 31, 2013—University of Washington

BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Marburg Virus Disease 
December 30, 2013—BioCryst Pharmaceuticals, Inc.

PDL-1 Antibody Could Help Immune System Fight off Influenza Viral Infection, Study Suggests 
December  23, 2013—Nationwide Children’s Hospital

New Vaccine from University of Iowa Protects Against Lethal Pneumonia Caused by Staph Bacteria 
December 20, 2013—University of Iowa

Biologists Find Clues to a Parasite’s Inconsistency 
December 19, 2013—MIT

Scientists Look to Tackle Bacterium That Is Major Cause of Diarrhea, Vomiting 
December 19, 2013—Medical College of Georgia at Georgia Regents University

Gladstone’s Discovery of Precise Molecular Mechanisms in the Human Body Leads to a New Potential Therapy for Our Era’s Deadliest Epidemic 
December 19, 2013—Gladstone Institutes

Tulane Pathologist Gets $2.6 Million in NIH Awards for Hepatitis C Research 
December 18, 2013—Tulane University

Discovery of Immune Avoidance Mechanism Could Lead to Treatments for Deadly Mosquito-borne Viruses 
December 18, 2013—University of Pittsburgh Center for Vaccine Research

New Anti-HIV Drug Target Identified by University of Minnesota Researchers 
December 18, 2013—University of Minnesota

Newly Identified Immune Receptor May Activate B Cells in Autoimmunity  
December 18, 2013—University of Alabama at Birmingham

Advances in HIV Treatment Dramatically Increase Life Expectancy 
December 18, 2013—British Columbia Centre for Excellence in HIV/AIDS

Latest Study Finds No Link Between HIV-Prevention Pill Truvada and Increased Sexual Risk Behavior; Underscores Drug’s Effectiveness at Preventing New Infections 
December 18, 2013—Gladstone Institutes

E. Coli Infections Traced to Single Strain of Bacteria 
December 17, 2013—George Washington University School of Public Health and Health Services

These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”